•The dual role of RIPK family in IBD: from cell death to therapeutic targeting
•M2 macrophage-based biohybrid system regulates intestinal microbiota homeostasis and immunity for the treatment of inflammatory bowel disease
•Magnoflorine, a dietary alkaloid from Alpinia oxyphylla fruit, ameliorates colitis by restoring intestinal barrier and dual modulation of JAK/STAT3 pathway
•Underevaluation of bowel urgency in clinical care: patient experiences and outcomes in ulcerative colitis: a retrospective cohort study
•Immunomodulatory biomaterials as a novel therapeutic platform for inflammatory bowel disease
